longbridge
Home
Community
Trade
Watchlist
LongbridgeAI

RSPH

----

Bio-Techne Corp Stock 12‑Month Price Target Raised to $66.42, Implies 13% Upside

TradingView
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Bio-Techne Corp's average 12-month price target has been raised to $66.42 by 12 analysts, up from $65.33, implying a 13% upside based on the June 24 closing price. The consensus rating remains 'Buy' across 19 covering analysts, with forecasts ranging from $50 to $75 per share.

  • According to estimates from 12 analysts, Bio-Techne Corp stock's average price target has risen from $65.33 to $66.42, with forecasts ranging from $50 to $75 per share
  • Based on the Jun. 24 closing price, the updated target implies approximately 13% potential upside
  • Consensus rating remains at “Buy” across 19 covering analysts, with 11 Buys, 7 Holds and 1 Sells

Explore more price target data and ratings for Bio-Techne Corp on the , and track all previous and future analyst recommendations for Bio-Techne Corp in the dedicated News Flow.

Disclaimer
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

Login to unlock254characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 Longbridge｜Terms of ServicePrivacy Policy